Trypanothione Reductase: A Target Protein for a Combined In Vitro and In Silico Screening Approach

Trypanothione Reductase: A Target Protein for a Combined In Vitro and In Silico Screening Approach

With the goal to identify novel trypanothione reductase (TR) inhibitors, we performed a combination of in vitro and in silico screening approaches. Starting from a highly diverse compound set of 2,816 compounds, 21 novel TR inhibiting compounds could be identified in the initial in vitro screening c...

Full description

Bibliographic Details
Main Authors:	Beig, Mathias, Oellien, Frank, Garoff, Linnéa, Noack, Sandra, Krauth-Siegel, R. Luise, Selzer, Paul M.
Format:	Online
Language:	English
Published:	Public Library of Science 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456413/

Similar Items

Footprinting of Inhibitor Interactions of In Silico Identified Inhibitors of Trypanothione Reductase of Leishmania Parasite
by: Venkatesan, Santhosh K., et al.
Published: (2012)

Mini review on tricyclic compounds as an inhibitor of trypanothione reductase
by: Kumar, Suresh, et al.
Published: (2014)

Dissecting the Catalytic Mechanism of Trypanosoma brucei Trypanothione Synthetase by Kinetic Analysis and Computational Modeling*
by: Leroux, Alejandro E., et al.
Published: (2013)

Trypanothione Reductase: A Viable Chemotherapeutic Target for Antitrypanosomal and Antileishmanial Drug Design
by: Khan, M. Omar F.
Published: (2007)

Molecular Dynamics Reveal Binding Mode of Glutathionylspermidine by Trypanothione Synthetase
by: Koch, Oliver, et al.
Published: (2013)

Dihydroquinazolines as a Novel Class of Trypanosoma brucei Trypanothione Reductase Inhibitors: Discovery, Synthesis, and Characterization of their Binding Mode by Protein Crystallography
by: Patterson, Stephen, et al.
Published: (2011)

Molecular modeling, structural analysis and identification of ligand binding sites of trypanothione reductase from <i>Leishmania mexicana</i>
by: Ozal Mutlu
Published: (2013-01-01)

Design, Synthesis and Biological Evaluation of Trypanosoma brucei Trypanothione Synthetase Inhibitors
by: Spinks, Daniel, et al.
Published: (2012)

Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids
by: Benítez, Diego, et al.
Published: (2016)

4th German Conference on Chemoinformatics: 22. CIC-Workshop. November 9–11, 2008, Goslar, Germany
by: Oellien, Frank
Published: (2009)

A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition
by: Ilari, Andrea, et al.
Published: (2011)

Stage-Dependent Expression and Up-Regulation of Trypanothione Synthetase in Amphotericin B Resistant Leishmania donovani
by: Equbal, Asif, et al.
Published: (2014)

3-Oxoacyl-ACP Reductase from Schistosoma japonicum: Integrated In Silico-In Vitro Strategy for Discovering Antischistosomal Lead Compounds
by: Liu, Jian, et al.
Published: (2013)

Health economic analysis of screening
by: Krauth, Christian
Published: (2010)

IspE Inhibitors Identified by a Combination of In Silico and In Vitro High-Throughput Screening
by: Tidten-Luksch, Naomi, et al.
Published: (2012)

In Silico-Based High-Throughput Screen for Discovery of Novel Combinations for Tuberculosis Treatment
by: Singh, Ragini, et al.
Published: (2015)

Engineering Tocopherol Selectivity in α-TTP: A Combined In Vitro/In Silico Study
by: Helbling, Rachel E., et al.
Published: (2012)

Hypothesis on Serenoa repens (Bartram) small extract inhibition of prostatic 5α-reductase through an in silico approach on 5β-reductase x-ray structure
by: Governa, Paolo, et al.
Published: (2016)

Cytosolic Peroxidases Protect the Lysosome of Bloodstream African Trypanosomes from Iron-Mediated Membrane Damage
by: Hiller, Corinna, et al.
Published: (2014)

GCC2011 – 25 years of computational chemistry meetings
by: Oellien, Frank, et al.
Published: (2012)

German Conference on Chemoinformatics 2010 – organizers' notes
by: Oellien, Frank, et al.
Published: (2011)

SIRT6 Is a Positive Regulator of Aldose Reductase Expression in U937 and HeLa cells under Osmotic Stress: In Vitro and In Silico Insights
by: Timucin, Ahmet Can, et al.
Published: (2016)

In Silico Screening of the Key Cellular Remodeling Targets in Chronic Atrial Fibrillation
by: Koivumäki, Jussi T., et al.
Published: (2014)

Farnesyl Diphosphate Synthase Inhibitors from In Silico Screening
by: Lindert, Steffen, et al.
Published: (2013)

An in silico platform for predicting, screening and designing of antihypertensive peptides
by: Kumar, Ravi, et al.
Published: (2015)

Network-based in silico drug efficacy screening
by: Guney, Emre, et al.
Published: (2016)

Identification of Semicarbazones, Thiosemicarbazones and Triazine Nitriles as Inhibitors of Leishmania mexicana Cysteine Protease CPB
by: Schröder, Jörg, et al.
Published: (2013)

Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening
by: Somsak, Voravuth, et al.
Published: (2011)

In Vivo, In Vitro, and In Silico Characterization of Peptoids as Antimicrobial Agents
by: Czyzewski, Ann M., et al.
Published: (2016)

Variability in respiratory rhythm generation: in vitro and in silico models
by: Fietkiewicz, Chris, et al.
Published: (2014)

In silico docking studies for designing potent anti-diabetic derivatives of swertiamarin with enzyme HMG COA reductase
by: Bhatt, Jayshil, et al.
Published: (2014)

Novel Natural Inhibitors of CYP1A2 Identified by in Silico and in Vitro Screening
by: Zhu, Ruixin, et al.
Published: (2011)

In-silico screening and in-vitro validation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR-2) inhibitors
by: Saraswat, Deepika, et al.
Published: (2014)

Discovery of Novel Ligands for Mouse Olfactory Receptor MOR42-3 Using an In Silico Screening Approach and In Vitro Validation
by: Bavan, Selvan, et al.
Published: (2014)

Identification of hepta-histidine as a candidate drug for Huntington’s disease by in silico-in vitro- in vivo-integrated screens of chemical libraries
by: Imamura, Tomomi, et al.
Published: (2016)

In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state
by: Aliper, Alexander, et al.
Published: (2016)

Discovery of Dual ETA/ETB Receptor Antagonists from Traditional Chinese Herbs through in Silico and in Vitro Screening
by: Wang, Xing, et al.
Published: (2016)

Putative histidine kinase inhibitors with antibacterial effect against multi-drug resistant clinical isolates identified by in vitro and in silico screens
by: Velikova, Nadya, et al.
Published: (2016)

In Silico Screening of Nonsteroidal Anti-Inflammatory Drugs and Their Combined Action on Prostaglandin H Synthase-1
by: Goltsov, Alexey, et al.
Published: (2010)

Combined In Silico, In Vivo, and In Vitro Studies Shed Insights into the Acute Inflammatory Response in Middle-Aged Mice
by: Namas, Rami A., et al.
Published: (2013)